Welcome to iPSC21

iPSC21 is the scientific division of SC21 group dedicated to human Induced Pluripotent Stem Cells (iPSC). Our scientific team and advisory board comprise of internationally acclaimed scientists from the iPSC field. This unmatched level of expertise and long-standing clinical experience in adult stem cells gives iPSC21 its uniqueness.

Our Services Process

From a sample of your skin or a portion of your newborn child’s umbilical cord, we can produce your iPSCs. Once the iPSCs are generated you will have an autologous immortal cell line capable of unlimited self-renewal.

We cryogenically preserve the induced pluripotent stem cells successfully created for future use as a cell culture source, personal drug testing tool, and for any future cellular medicine innovations that are developed.

We can use your iPSCs as an unlimited source for differentiation into therapeutically usable cells. At present, we provide differentiation services for iPSC-derived MSCs which hold higher regenerative potential than tissue sources of MSCs.

What are Induced Pluripotent Stem Cells?

iPSCs are derived from adult cells such as skin cells that have been reprogrammed back into an embryonic-like pluripotent state. The generated iPSCs can perform unlimited self-renewal and can be differentiated into any cell type in the human body. For example, they can become beta islet cells to treat or research diabetes, or neurons to treat or research neurological disorders.

In 2006, Japanese scientists led by nobel price winner Shinya Yamanaka converted skin cells with a variety of transcription factors (proteins that can turn genes “on” or “off”) to genetically “reprogram” them to be stem cells, which he called induced pluripotent stem cells (iPSCs).

Part of the SC21 Group